Deprescribing Anticholinergic Medications in Hospitalised Older Adults: A Systematic Review

减少住院老年患者抗胆碱能药物用量:系统评价

阅读:2

Abstract

BACKGROUND: Anticholinergic medication use is increasing, particularly among older adults due to polypharmacy and comorbidities. High anticholinergic burden is linked to adverse outcomes such as reduced mobility and increased dementia risk. Acute hospital stays may offer an opportunity to address this often-overlooked issue. AIMS: To examine the effects of deprescribing anticholinergic medications on outcomes in older hospitalised patients. METHODS: Medline, Web of Science, Cochrane Library and Embase were searched from inception to September 2024. Studies included hospital-based deprescribing or medication review interventions targeting anticholinergic burden in patients aged ≥ 65 years. Narrative synthesis followed SWiM guidelines, with quality assessment using JBI Checklists. RESULTS: From 2042 records, eight studies met inclusion criteria. Designs included cohort (n = 4) and pre-post quasi-experimental (n = 4), with follow-up durations of up to 3 months. All reported medication-related outcomes; four assessed acceptability, one included clinical outcomes, and none examined safety. Six studies reported reductions in anticholinergic burden scores; three showed significant decreases in the proportion of patients prescribed anticholinergics, and two noted fewer potentially inappropriate medications. Most recommended changes were implemented. CONCLUSION: Deprescribing interventions in hospital appear acceptable and effective in reducing anticholinergic burden. However, evidence on clinical outcomes, costs and safety is limited. Further RCTs with longer follow-up are needed.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。